Inhibition of heat shock protein response enhances PS-341-mediated glioma cell death

Annals of Surgical Oncology

Volumn 19, Issue SUPPL. 3, 2012, Pages

  Liu, Yaohua ^a   Zheng, Tianhu ^b   Zhao, Shiguang ^a   Liu, Huailei ^a   Han, Dayong ^a   Zhen, Yunbo ^a   Xu, Dongxiao ^a   Wang, Yu ^a   Yang, Hongyu ^a   Zhang, Guang ^a   Wang, Chunlei ^a   Wu, Jianing ^a   Ye, Yuanzhu ^a  

^a THE FIRST AFFILIATED HOSPITAL OF HARBIN MEDICAL UNIVERSITY   (China)

^b HARBIN MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

BORTEZOMIB; HEAT SHOCK PROTEIN 40; HEAT SHOCK PROTEIN 70; HEAT SHOCK TRANSCRIPTION FACTOR 1; JANUS KINASE;

ARTICLE; BRAIN TISSUE; CELL DAMAGE; CELL DEATH; CELLULAR STRESS RESPONSE; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG EFFECT; GLIOMA CELL; HUMAN; HUMAN CELL; HUMAN TISSUE; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; UPREGULATION;

ANTINEOPLASTIC AGENTS; APOPTOSIS; BENZHYDRYL COMPOUNDS; BORONIC ACIDS; BRAIN; CELL LINE, TUMOR; CELL NUCLEUS; DNA-BINDING PROTEINS; GENE KNOCKDOWN TECHNIQUES; GLIOBLASTOMA; HOT TEMPERATURE; HSP40 HEAT-SHOCK PROTEINS; HSP70 HEAT-SHOCK PROTEINS; HUMANS; JNK MITOGEN-ACTIVATED PROTEIN KINASES; PHOSPHORYLATION; PYRAZINES; PYRROLIDINONES; RNA, SMALL INTERFERING; TRANSCRIPTION FACTORS; UP-REGULATION;

EID: 84865008207     PISSN: 10689265     EISSN: 15344681     Source Type: Journal    
DOI: 10.1245/s10434-011-1881-2     Document Type: Article

References (33)

1. R Nishikawa 2010 Standard therapy for glioblastoma-a review of where we are Neurol Med Chir (Tokyo) 50 9 713 719 10.2176/nmc.50.713
2. R Stupp ME Hegi, et al. 2009 Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial Lancet Oncol 10 5 459 466 19269895 10.1016/S1470-2045(09)70025-7 1:CAS:528: DC%2BD1MXlsVKhs74%3D
3. R Stupp WP Mason, et al. 2005 Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma N Engl J Med 352 10 987 996 15758009 10.1056/NEJMoa043330 1:CAS:528:DC%2BD2MXit1Wksbk%3D
4. S Fulda W Wick, et al. 2002 Smac agonists sensitize for Apo2L/TRAIL- or anticancer drug-induced apoptosis and induce regression of malignant glioma in vivo Nat Med 8 8 808 815 12118245 1:CAS:528:DC%2BD38Xls12msbw%3D
5. GN Demartino TG Gillette 2007 Proteasomes: machines for all reasons Cell 129 4 659 662 17512401 10.1016/j.cell.2007.05.007 1:CAS:528:DC%2BD2sXmtFGqurc%3D
6. JB Almond GM Cohen 2002 The proteasome: a novel target for cancer chemotherapy Leukemia 16 4 433 443 11960320 10.1038/sj.leu.2402417 1:CAS:528:DC%2BD38XjvFGnur8%3D
7. J Adams 2002 Proteasome inhibitors as new anticancer drugs Curr Opin Oncol 14 6 628 634 12409653 10.1097/00001622-200211000-00007 1:CAS:528:DC%2BD38XosFegtLs%3D
8. Y Yang J Kitagaki, et al. 2009 Targeting the ubiquitin-proteasome system for cancer therapy Cancer Sci 100 1 24 28 19037995 10.1111/j.1349-7006.2008. 01013.x 1:CAS:528:DC%2BD1MXhtlGgurk%3D
9. J Adams 2002 Preclinical and clinical evaluation of proteasome inhibitor PS-341 for the treatment of cancer Curr Opin Chem Biol 6 4 493 500 12133726 10.1016/S1367-5931(02)00343-5 1:CAS:528:DC%2BD38XlsVyjur0%3D
10. J Adams VJ Palombella, et al. 1999 Proteasome inhibitors: a novel class of potent and effective antitumor agents Cancer Res 59 11 2615 2622 10363983 1:CAS:528:DyaK1MXjs1ymsbY%3D
11. YH Ling L Liebes, et al. 2003 Mechanisms of proteasome inhibitor PS-341-induced G(2)-M-phase arrest and apoptosis in human non-small cell lung cancer cell lines Clin Cancer Res 9 3 1145 1154 12631620 1:CAS:528: DC%2BD3sXhvFKitbs%3D
12. BH Yeung DC Huang, et al. 2006 PS-341 (bortezomib) induces lysosomal cathepsin B release and a caspase-2-dependent mitochondrial permeabilization and apoptosis in human pancreatic cancer cells J Biol Chem 281 17 11923 11932 16446371 10.1074/jbc.M508533200 1:CAS:528:DC%2BD28Xjslens7s%3D
13. ST Nawrocki CJ Bruns, et al. 2002 Effects of the proteasome inhibitor PS-341 on apoptosis and angiogenesis in orthotopic human pancreatic tumor xenografts Mol Cancer Ther 1 14 1243 1253 12516957 1:CAS:528: DC%2BD3sXmtFamuw%3D%3D
14. D Yin H Zhou, et al. 2005 Proteasome inhibitor PS-341 causes cell growth arrest and apoptosis in human glioblastoma multiforme (GBM) Oncogene 24 3 344 354 15531918 10.1038/sj.onc.1208225 1:CAS:528:DC%2BD2MXnsFSgtQ%3D%3D
15. PF Bross R Kane, et al. 2004 Approval summary for bortezomib for injection in the treatment of multiple myeloma Clin Cancer Res 10 12 Pt 1 3954 3964 15217925 10.1158/1078-0432.CCR-03-0781 1:CAS:528:DC%2BD2cXltFWmtLk%3D
16. S Phuphanich JG Supko, et al. 2010 Phase 1 clinical trial of bortezomib in adults with recurrent malignant glioma J Neurooncol 100 1 95 103 20213332 10.1007/s11060-010-0143-7 1:CAS:528:DC%2BC3cXht1Krsb3E
17. G Roue P Perez-Galan, et al. 2011 The Hsp90 inhibitor IPI-504 overcomes bortezomib resistance in mantle cell lymphoma in vitro and in vivo by down-regulation of the prosurvival ER chaperone BiP/Grp78 Blood 117 4 1270 1279 21106982 10.1182/blood-2010-04-278853 1:CAS:528:DC%2BC3MXhvFGks7o%3D
18. S Hayashi M Yamamoto, et al. 2001 Expression of nuclear factor-kappa B, tumor necrosis factor receptor type 1, and c-Myc in human astrocytomas Neurol Med Chir (Tokyo) 41 4 187 195 10.2176/nmc.41.187 1:STN:280: DC%2BD3M3psVymtg%3D%3D
19. R Koschny H Holland, et al. 2007 Bortezomib sensitizes primary human astrocytoma cells of WHO grades I to IV for tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis Clin Cancer Res 13 11 3403 3412 17545549 10.1158/1078-0432.CCR-07-0251 1:CAS:528:DC%2BD2sXmtVaisrc%3D
20. Z Tianhu Z Shiguang, et al. 2010 Bmf is upregulated by PS-341-mediated cell death of glioma cells through JNK phosphorylation Mol Biol Rep 37 3 1211 1219 19267218 10.1007/s11033-009-9491-9
21. N Mitsiades CS Mitsiades, et al. 2002 Molecular sequelae of proteasome inhibition in human multiple myeloma cells Proc Natl Acad Sci USA 99 22 14374 14379 12391322 10.1073/pnas.202445099 1:CAS:528:DC%2BD38XosF2iu7Y%3D
22. RI Morimoto MP Kline, et al. 1997 The heat-shock response: regulation and function of heat-shock proteins and molecular chaperones Essays Biochem 32 17 29 9493008 1:CAS:528:DyaK1cXktVSrsQ%3D%3D
23. M Koishi S Yokota, et al. 2001 The effects of KNK437, a novel inhibitor of heat shock protein synthesis, on the acquisition of thermotolerance in a murine transplantable tumor in vivo Clin Cancer Res 7 1 215 219 11205912 1:CAS:528:DC%2BD3MXht1Wht7s%3D
24. HC Drexler 1997 Activation of the cell death program by inhibition of proteasome function Proc Natl Acad Sci USA 94 3 855 860 9023346 10.1073/pnas.94.3.855 1:CAS:528:DyaK2sXhtVOltLc%3D
25. Masdehors PS Omura, et al. 1999 Increased sensitivity of CLL-derived lymphocytes to apoptotic death activation by the proteasome-specific inhibitor lactacystin Br J Haematol 105 3 752 757 10354141 10.1046/j.1365-2141.1999.01388. x 1:CAS:528:DyaK1MXkt1Orur0%3D
26. PG Richardson C Mitsiades 2005 Bortezomib: proteasome inhibition as an effective anticancer therapy Future Oncol 1 2 161 171 16555986 10.1517/14796694.1.2.161 1:CAS:528:DC%2BD2MXktlOmtb4%3D
27. A Badros AM Burger, et al. 2009 Phase I study of vorinostat in combination with bortezomib for relapsed and refractory multiple myeloma Clin Cancer Res 15 16 5250 5257 19671864 10.1158/1078-0432.CCR-08-2850 1:CAS:528:DC%2BD1MXpvFeit7Y%3D
28. MN Saha H Jiang, et al. 2010 MDM2 antagonist nutlin plus proteasome inhibitor velcade combination displays a synergistic anti-myeloma activity Cancer Biol Ther 9 11 936 944 20418664 10.1158/1535-7163.MCT-10-0471 1:CAS:528:DC%2BC3cXhtlKgt73M
29. S Meister B Frey, et al. 2010 Calcium channel blocker verapamil enhances endoplasmic reticulum stress and cell death induced by proteasome inhibition in myeloma cells Neoplasia 12 7 550 561 20651984 1:CAS:528:DC%2BC3cXovFGrtrg%3D
30. JT Young JJ Heikkila 2010 Proteasome inhibition induces hsp30 and hsp70 gene expression as well as the acquisition of thermotolerance in Xenopus laevis A6 cells Cell Stress Chaperones 15 3 323 334 19838833 10.1007/s12192-009-0147-4 1:CAS:528:DC%2BC3cXktlSit7o%3D
31. R Sarkozi P Perco, et al. 2008 Bortezomib-induced survival signals and genes in human proximal tubular cells J Pharmacol Exp Ther 327 3 645 656 18776064 10.1124/jpet.108.142604
32. HS Park JS Lee, et al. 2001 Hsp72 functions as a natural inhibitory protein of c-Jun N-terminal kinase EMBO J 20 3 446 456 11157751 10.1093/emboj/20.3.446 1:CAS:528:DC%2BD3MXitFGqtrY%3D
33. AB Meriin JA Yaglom, et al. 1999 Protein-damaging stresses activate c-Jun N-terminal kinase via inhibition of its dephosphorylation: a novel pathway controlled by HSP72 Mol Cell Biol 19 4 2547 2555 10082520 1:CAS:528: DyaK1MXit1amsb0%3D